SCHEMBL24286462

SCHEMBL24286462

COc1cc(S(=O)(=O)N2CCOc3ccc(-c4cc(F)cc(OC)c4F)cc32)ccc1F

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.47
▸ POLB P06746 2/20 0.47
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ CYP2C9 P11712 1/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ PKM P14618 2/20 0.41
▸ PKLR P30613 2/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ RORC P51449 6/20 0.40
▸ CPT2 P23786 2/20 0.40
▸ CPT1A P50416 2/20 0.40
▸ CPT1B Q92523 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24286298 0.91 ALDH1A1 (0.49) ALDH1A1POLBCYP3A4CYP2D6SMN1; SMN2
SCHEMBL24286495 0.89 CYP3A4 (0.49) ALDH1A1POLBCYP3A4CYP2D6SMN1; SMN2
SCHEMBL24286809 0.86 CYP2C9 (0.51) ALDH1A1POLBCYP3A4CYP2D6SMN1; SMN2
SCHEMBL24286265 0.85 RORC (0.49) POLBPKMPKLRRORC
SCHEMBL24286256 0.82 CYP3A4 (0.53) ALDH1A1POLBCYP3A4CYP2D6SMN1; SMN2
SCHEMBL24286304 0.82 NPC1 (0.52) ALDH1A1POLBCYP3A4CYP2D6SMN1; SMN2
SCHEMBL24286286 0.78 POLB (0.46) ALDH1A1POLBCYP3A4CYP2D6SMN1; SMN2
SCHEMBL24286653 0.75 RORC (0.54) RORC
SCHEMBL24286546 0.74 RORC (0.51) PKMPKLRRORC
SCHEMBL1818459 0.74 POLB (0.47) ALDH1A1POLBCYP3A4CYP2D6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3307738-B1 ARYL DIHYDRO-2H-BENZO[B][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORY AND THE TREATMENT OF DISEASE UNIV MICHIGAN REGENTS (US) 2022-04-20 — — EP disclosed
Send feedback